Of Chain Drug Stores- breakthrough new medical reform.doc

 PAGE \* MERGEFORMAT 6 Of Chain Drug Stores: breakthrough new medical reform 1, the new policy on medical reform the political chain of negative effects of the retail chain Lack of policy support. The new medical reform program, only in a third major section, seventh dot - ‘(7) Establish and improve drug supply support system’, referring to drug retail ‘... ... the development of modern logistics and chain drug ... ...’ Looking back, it the eight words. Furthermore, the entire text to read, not seen on the pharmaceutical retail sales in the new position and role of medical reform in the description of almost all the policy guidance is to support medical units to the main health system. In particular, the state will vigorously support the third terminal and fourth terminal (community health centers and community health service stations) mainly from the system, drug procurement, drug selection, matching the cost reimbursement provisions that are beneficial to medical units and systems, Drug Retail thoroughly marginalized, not the drug retail industry, location, government subsidies for medical institutions, making, drug retailing is not competitive. Adverse drug prices policy. In addition, we can see from the program, the state will complete the reform of drug pricing mechanism, clearly stipulates: ‘right after the implementation of generic drugs market prices from the low pricing system survive and suppress low-level duplicated construction. Marked on the implementation of packaging in the pharmaceutical pricing system. Strictly control the rate of drug circulation difference. ‘We know that the vast majority of pharmacies selling drugs old drugs, generic drugs and new generic drugs, from low-priced but also clearly marked on the outer box, a direct result of this policy is to present the main pharmacy in full swing to push higher-margin products will come to an end, difficult to sustain. From which point of view, these medical reform programs on the retail